Published in Leukemia on August 26, 2010
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood (2012) 2.52
Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations. EMBO Mol Med (2012) 1.22
Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc (2014) 1.12
MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3θ. PLoS One (2012) 1.04
Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression. Leukemia (2012) 0.86
Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design. Clin Cancer Res (2016) 0.84
Murine models of acute leukemia: important tools in current pediatric leukemia research. Front Oncol (2014) 0.84
Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia. Exp Hematol Oncol (2013) 0.81
Targeting tumour-initiating cells with TRAIL based combination therapy ensures complete and lasting eradication of multiple myeloma tumours in vivo. PLoS One (2012) 0.81
In Silico cancer cell versus stroma cellularity index computed from species-specific human and mouse transcriptome of xenograft models: towards accurate stroma targeting therapy assessment. BMC Med Genomics (2014) 0.80
Uncovering low-dimensional, miR-based signatures of acute myeloid and lymphoblastic leukemias with a machine-learning-driven network approach. Converg Sci Phys Oncol (2015) 0.78
Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice. Front Oncol (2016) 0.77
Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology. Blood (2014) 0.77
Generation of human acute lymphoblastic leukemia xenografts for use in oncology drug discovery. Curr Protoc Pharmacol (2015) 0.77
Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. Oncotarget (2016) 0.75
Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia. PLoS One (2016) 0.75
Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet (2017) 0.75
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
The cancer genome. Nature (2009) 23.13
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 21.59
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature (2006) 11.90
Treatment of acute lymphoblastic leukemia. N Engl J Med (2006) 11.30
Tumor growth need not be driven by rare cancer stem cells. Science (2007) 10.34
Humanized mice in translational biomedical research. Nat Rev Immunol (2007) 8.83
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood (2005) 6.16
Mutational analysis of the tyrosine kinome in colorectal cancers. Science (2003) 5.43
Characterization of clonogenic multiple myeloma cells. Blood (2003) 5.35
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol (2007) 5.21
Immunotoxin therapy of cancer. Nat Rev Cancer (2006) 3.93
Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science (2008) 3.38
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood (2008) 3.19
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies. Blood (2004) 3.13
Modeling the initiation and progression of human acute leukemia in mice. Science (2007) 2.90
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell (2008) 2.78
Characterization of acute lymphoblastic leukemia progenitor cells. Blood (2004) 2.65
Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains. Int J Cancer (2008) 2.45
A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood (2000) 2.42
Comment on "Tumor growth need not be driven by rare cancer stem cells". Science (2007) 2.41
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med (2005) 2.36
Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med (2003) 2.31
The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci U S A (1992) 2.28
Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood (2010) 2.19
Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res (2008) 1.99
Looking ahead in cancer stem cell research. Nat Biotechnol (2009) 1.89
Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol Ther (2008) 1.83
Expression of CD133 on leukemia-initiating cells in childhood ALL. Blood (2009) 1.71
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. Cancer Res (2005) 1.55
Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood (1999) 1.52
Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling. Blood (2003) 1.48
Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics. Semin Oncol (2008) 1.39
CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia (2008) 1.39
Human AML cells in NOD/SCID mice: engraftment potential and gene expression. Leukemia (2002) 1.30
Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia. Blood (2009) 1.21
Trends in childhood cancer mortality--United States, 1990-2004. MMWR Morb Mortal Wkly Rep (2007) 1.18
Internal tandem duplications of the FLT3 gene are present in leukemia stem cells. Blood (2005) 1.18
Good engraftment of B-cell precursor ALL in NOD-SCID mice. Klin Padiatr (1997) 1.12
Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal. Blood (2002) 1.12
Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival. Stem Cells (2004) 1.11
Progress in the treatment of adults with acute lymphoblastic leukemia. Curr Opin Hematol (2008) 1.09
Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. Blood (1999) 0.99
Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice. Blood (1991) 0.95
Malignant stem cells in childhood acute lymphoblastic leukemia: the stem cell concept revisited. Cell Cycle (2009) 0.89
Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study. Leuk Lymphoma (1998) 0.84
Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice. Exp Hematol (2010) 0.82
Long-term proliferation of human leukemia cells induced by mouse stroma. Exp Hematol (1989) 0.81
Growth requirements and immunophenotype of acute lymphoblastic leukemia progenitors. Blood (2005) 0.81
In vivo models of childhood leukemia for preclinical drug testing. Curr Drug Targets (2007) 0.79
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (1992) 17.40
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med (2001) 16.65
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48
Vascular-specific growth factors and blood vessel formation. Nature (2000) 14.42
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell (1996) 13.95
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science (1988) 9.05
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature (1990) 8.94
Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet (1969) 8.94
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res (2001) 8.34
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (1997) 8.05
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet (1997) 5.58
Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med (1994) 5.32
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol (1986) 5.27
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf (2002) 5.20
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (1974) 4.95
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet (1996) 4.59
Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol (1984) 4.55
Human immunodeficiency virus integration in a cell-free system. J Virol (1990) 4.48
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
CD34: structure, biology, and clinical utility. Blood (1996) 4.41
Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron (1996) 4.12
Genetic control of natural variation in Arabidopsis glucosinolate accumulation. Plant Physiol (2001) 4.07
Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science (1994) 4.07
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science (1992) 3.93
DPC4 gene in various tumor types. Cancer Res (1996) 3.74
A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci (2001) 3.56
Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis (2000) 3.41
B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med (1996) 3.35
Community clinics for leg ulcers and impact on healing. BMJ (1992) 3.28
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med (1999) 3.18
A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood (1992) 3.18
Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin. Br Med J (1967) 3.15
A three-item scale for the early prediction of stroke recovery. Lancet (2001) 3.15
Transfer of anibioic resistanceetween Pseudomonas aeruginosa, Escherichia coli, and other gram-negative bacilli in rns. Lancet (1971) 3.05
Sacral fractures: an important problem. Retrospective analysis of 236 cases. Clin Orthop Relat Res (1988) 3.04
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Comparative genome organization of vertebrates. The First International Workshop on Comparative Genome Organization. Mamm Genome (1996) 2.97
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (1995) 2.92
An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell (1997) 2.89
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol (1989) 2.89
CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell (1992) 2.83
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci U S A (1999) 2.77
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Bias inherent in retrospective waiting-time studies: experience from a vascular surgery waiting list. CMAJ (2000) 2.74
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant (2002) 2.69
An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci U S A (1997) 2.67
Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer (1995) 2.65
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Engl J Med (2001) 2.65
Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes (1993) 2.63
Seismicity remotely triggered by the magnitude 7.3 landers, california, earthquake. Science (1993) 2.61
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet (2004) 2.51
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med (2001) 2.47
Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa. Br J Exp Pathol (1968) 2.47
Further evidence for small-bodied hominins from the Late Pleistocene of Flores, Indonesia. Nature (2005) 2.47
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology (1987) 2.46
Refining the perfusion-diffusion mismatch hypothesis. Stroke (2005) 2.44
An extremely luminous X-ray outburst at the birth of a supernova. Nature (2008) 2.41
Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A (2001) 2.36
Kernel abortion in maize : I. Carbohydrate concentration patterns and Acid invertase activity of maize kernels induced to abort in vitro. Plant Physiol (1986) 2.36
Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med (1997) 2.36
Epidemiological characteristics of adenocarcinoma of the gastric cardia and distal stomach in the United States, 1973-1982. Int J Epidemiol (1988) 2.36
Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene (1997) 2.35
trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell (1991) 2.31
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30
Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials. Cancer (1985) 2.28
The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci U S A (1992) 2.28
"Viable motheaten," a new allele at the motheaten locus. I. Pathology. Am J Pathol (1984) 2.26
New clinical sign for orthostatic tremor. Lancet (1995) 2.25
Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. Science (1986) 2.24
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett (2000) 2.22
Antiserum and antibiotic in the prophylaxis of burns against Pseudomonas aeruginosa. Br J Plast Surg (1966) 2.21
Gastric cancer detection in gastric ulcer disease. Gut (1980) 2.20
Gamma-interferon is one of several direct B cell-maturing lymphokines. Nature (1984) 2.18
Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem (1985) 2.18
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. J Pharmacol Exp Ther (1965) 2.16
Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood (1987) 2.15
Bovine spongiform encephalopathy [corrected] Creutzfeldt-Jakob disease. BMJ (1996) 2.15
A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest (1992) 2.13
Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood (1996) 2.12
Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res (1997) 2.12
Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med (1993) 2.10
Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med (1977) 2.10
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet (1994) 2.09